190 likes | 301 Views
AU European Forum, Divonne 11-12 mars 2004. In the last ten years, two new professionnal services have been developped in Switzerland: Consultant pharmacist in Quality Circles formed with GP’s, focused on medecines’ prescription. Accepted and paid by Insurance Companies
E N D
AU European Forum, Divonne 11-12 mars 2004 • In the last ten years, two new professionnal services have been • developped in Switzerland: • Consultant pharmacist in Quality Circles formed with GP’s, • focused on medecines’ prescription. • Accepted and paid by Insurance Companies • Consultant pharmacist in Nursing Home • Recognized by the law and paid by Insurance Companies Michel Buchmann Dr pharmacien
AU European Forum, Divonne 11-12 mars 200 Definition of a Quality Circle • A stable group of 5 to 15 doctors and pharmacist • Acceptation to have meetings together • Evaluation of the every day practice of prescription • Based on their own and actual prescrition’s datas • With the help of a moderator • Finding ideas to optimize the practice • Putting in place guidelines • A continous evaluation of the success of the common decisions that have been taken • That means that every participants are active!! And not sleeping!! Michel Buchmann Dr pharmacien
AU European Forum, Divonne 11-12 mars 2004 Work processContinous development of the prescription 1.Prescription data (benchmarking per physician and therapeutic class) 7.Assessment of the results and improvements 2.Education on guidelines, evidence base medecine and pharmacoeconomy. 6.Implementation of the consensus 3.Analysis of prescription attitudes in comparison with scientific and economic data and search for alternatives in drug market 5.Application of the consensus 4.Consensus of each quality circle Michel Buchmann Dr pharmacien
AU European Forum, Divonne 11-12 mars 2004 Evaluation of the results • Through the growth of the project in Switzerland and the personal satisfaction of the participants • Through the economical impact on the costs of the prescription • Through the fact that our observations could be recognized by politicians as: • a national benchmarking of the medical prescription • a follow up of the medecines’ market • an analyse of the practice compared with international consensus and guidelines Michel Buchmann Dr pharmacien
AU European Forum, Divonne 11-12 mars 2004 Evolution of the number of pharmacists and doctors involved in QCon a national level 1997: 9 circles (FR), about 35 physicians, 15 pharmacists 1998: 6 circles (FR),about 27 physicians, 11 pharmacists 2000: 13 circles (new: 4 in Geneva et 3 in Winterthur), about 90 physicians, 20 pharmacists 2001: 23 circles (new: 9 inFribourg et 1 in Argovie) 2002: More than 180 pharmacists involved in specialized education programs 2003: More than 300 physicians in about 30 circles, more than 50 pharmacists and about 150 pharmacists involved in continuing education, in 7 cantons (FR, GE, ZH, AG, VS, NE, BE) But... only 1 signed agreement in Fribourg with 4 companies(CSS, Helsana, Groupe Mutuel et Visana) and, actually, negociation on the national level to introduce finally a national agreement in 2005. Michel Buchmann Dr pharmacien
AU European Forum, Divonne 11-12 mars 2004 Schweizerischer ApothekerverbandSociété Suisse des PharmaciensSocietà Svizzera dei Farmacisti Evolution (index) of the report cost/pat due to the prescriptions of the firstdoctors active in the first Quality circles(1997-2003) (LS+taxes) O.Bugnon / 2004 Source de données brutes : OFAC (2003)
AU European Forum, Divonne 11-12 mars 2004 Money Saving between 1999-2002 • Medicines’ costs for 24 doctors « pionniers » en 2002: Fr. 12’941’039.60 for 25’101 patients (VAT and taxes included) • 9% of money savings between 1999 and 2002 compared to the evolution of a control group of 79 french speaking doctors. • = Fr. 48’528.90 of saving per physician • = Fr. 46.40 per patient Source de données brutes : OFAC (2003) Michel Buchmann Dr pharmacien
AU European Forum, Divonne 11-12 mars 2004 Results related to the effective participation to the work of the QC Source de données brutes : OFAC (2003) Michel Buchmann Dr pharmacien
AU European Forum, Divonne 11-12 mars 2004 Retained principles for the payement of the work done in QC: 1. The Insurance companies are paying to the QC half of the money saved in a year but a maximum of Eur 14 ’000.- 2. The payement of the doctors depend of their participation to the working group (Eur 180.-/meeting) 3. The administrative costs (Eur 1000.-/an) and the impact studies are partially taken in charge by the Insurance companies. Michel Buchmann Dr pharmacien
Schweizerischer ApothekerverbandSociété Suisse des PharmaciensSocietà Svizzera dei Farmacisti AU European Forum, Divonne 11-12 mars 2004 Impact study 2000-2002Evolution of the NAIDS Generics prescription O.Bugnon / 2004 Source de données brutes : OFAC (2003)
AU European Forum, Divonne 11-12 mars 2004 Michel Buchmann Dr pharmacien
Schweizerischer ApothekerverbandSociété Suisse des PharmaciensSocietà Svizzera dei Farmacisti AU European Forum, Divonne 11-12 mars 2004 Impact study 2000-2002Evolution of the prescription of the NAIDS undergroup Coxibes O.Bugnon / 2004 Source de données brutes : OFAC (2003)
AU European Forum, Divonne 11-12 mars 2004 Michel Buchmann Dr pharmacien
AU European Forum, Divonne 11-12 mars 2004 • Consultant pharmacist in nursing home means: • A practice based on the principle of the QC but in a • restricted area, in fact in nursing home. • A practice of medication review using the datas • written in the patient ’s charts • A link with logistical work ( (buying management, • stock management etc) Michel Buchmann Dr pharmacien
AU European Forum, Divonne 11-12 mars 2004 Tarif agreement • 1. Single payment for drugs and medical supply (6 Euros/patient/day) • 2. Financing of the pharmaceutical service (67 Euro Cent/patient/day) • Each institution declares its annual results with transparency • Distribution of possible benefits • 40% of any benefits are refunded to the institution as an incentive and a reward for good management • 60% are paid into a pool • 5. Use of the pool to offset deficits and evaluate the appropriateness of the lump sum • 6. In the event of a systematic, repeated deficit: independent evaluation by an expert Michel Buchmann Dr pharmacien Assistance pharmaceutique/ Buchmann, Bugnon (SSPh) 2001
Evolution of the cost/pat in 2 nursing homes working with a consultant pharmacist since 1995 2500 2000 1500 Coût eff/pat [fr] 1000 500 0 1995 1996 1997 1998 1999 2000 2001 2002 1er sem 03x2 RsMCot NDSiv AU European Forum, Divonne 11-12 mars 2004 Total: 110 patients Michel Buchmann Dr pharmacien
2800.00 2648.00 2600.00 +11.1% 2400.00 2427.00 +8.9% 2200.00 2329.00 2185.00 - 4.1% Coût médicaments annuel moyen par résident [Fr] 2000.00 +11.3% 2007.00 1800.00 1803.00 1600.00 Comptes AFIPA 1400.00 Projection 1200.00 AFIPA 1000.00 1998 1999 2000 2001 2002 AU European Forum, Divonne 11-12 mars 2004 Evolution of the annual cost/pat forpatients living in 30 nursing home 2002 being the first year of activity of consultant pharmacists in nursing home, we can see the impact , of their activities on the costs for 1437 patients: a decrease of 4.1% in place of a growth of about 10% Michel Buchmann Dr pharmacien
AU European Forum, Divonne 11-12 mars 2004 Added Value message: « As GP and member of a quality circle and as physician active in a nursing home, I can declare that: • the informatic tools are in place • the performance is growing • the working methods are in place • the collaboration between doctors, pharmacists and nurses is working and becomes better every year. » Dr Richard Nyffeler, médecin, 11.2003 Michel Buchmann Dr pharmacien
AU European Forum, Divonne 11-12 mars 2004 « What pharmacists understand and are knowledgeable about, are in fact, medicines. It is within this domain that they are indispensable. In the future, pharmacists should take on the selection of specific medecines, cooperating with prescribers, thus ensuring the safe and effective use of medicines by the patients. There is so much to do in these domains! Prescribing is largely irrational and patients are facing alone their treatment! » Philip Brown, FIP Congress The Hague, 1998 Michel Buchmann Dr pharmacien